Central IRF4/5 Signaling Are Critical for Microglial Activation and Impact on Stroke Outcomes
Translational Stroke Research · 2024
DOI: 10.1007/s12975-023-01172-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Stroke Research, 2024. Verfasst von Conelius Ngwa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. Hauptthemen laut MEDLINE: Interferon Regulatory Factors, Microglia, Signal Transduction, Stroke. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIH HHS, NIH.
Themen: Schlaganfall
Abstract (Originalsprache)
Microglia and monocytes play a critical role in immune responses to cerebral ischemia. Previous studies have demonstrated that interferon regulatory factor 4 (IRF4) and IRF5 direct microglial polarization after stroke and impact outcomes. However, IRF4/5 are expressed by both microglia and monocytes, and it is not clear if it is the microglial (central) or monocytic (peripheral) IRF4-IRF5 regulatory axis that functions in stroke. In this work, young (8-12 weeks) male pep boy (PB), IRF4 or IRF5 flox, and IRF4 or IRF5 conditional knockout (CKO) mice were used to generate 8 types of bone marrow chimeras, to differentiate the role of central (PB-to-IRF CKO) vs. peripheral (IRF CKO-to-PB) phagocytic IRF4-IRF5 axis in stroke. Chimeras generated from PB and flox mice were used as controls. All chimeras were subjected to 60-min middle cerebral artery occlusion (MCAO) model. Three days after the stroke, outcomes and inflammatory responses were analyzed. We found that PB-to-IRF4 CKO chimeras had more robust microglial pro-inflammatory responses than IRF4 CKO-to-PB chimeras, while ameliorated microglial response was seen in PB-to-IRF5 CKO vs. IRF5 CKO-to-PB chimeras. PB-to-IRF4 or IRF5 CKO chimeras had worse or better stroke outcomes respectively than their controls, whereas IRF4 or 5 CKO-to-PB chimeras had similar outcomes compared to controls. We conclude that the central IRF4/5 signaling is responsible for microglial activation and mediates stroke outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
- Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. Fudong.Liu@uth.tmc.edu.
Förderung
- NINDS NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Ngwa, C., Al Mamun, A., Qi, S., Sharmeen, R., Conesa, M. P. B., Ganesh, B. P., Manwani, B., & Liu, F. (2024). Central IRF4/5 Signaling Are Critical for Microglial Activation and Impact on Stroke Outcomes. Translational Stroke Research. https://doi.org/10.1007/s12975-023-01172-2
Vancouver
Ngwa C, Al Mamun A, Qi S, Sharmeen R, Conesa MPB, Ganesh BP, et al. Central IRF4/5 Signaling Are Critical for Microglial Activation and Impact on Stroke Outcomes. Translational Stroke Research. 2024. doi:10.1007/s12975-023-01172-2
BibTeX
@article{Ngwa2024,
author = {Ngwa, Conelius and Al Mamun, Abdullah and Qi, Shaohua and Sharmeen, Romana and Conesa, Maria P Blasco and Ganesh, Bhanu P and Manwani, Bharti and Liu, Fudong},
title = {Central IRF4/5 Signaling Are Critical for Microglial Activation and Impact on Stroke Outcomes},
journal = {Translational Stroke Research},
year = {2024},
doi = {10.1007/s12975-023-01172-2}
}
EUVIMED